Metastatic Medullary Thyroid Cancer
Also known as: Metastatic Thyroid Gland Medullary Carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB05294 | Vandetanib | An antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB01073 | Fludarabine | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB00945 | Acetylsalicylic acid | 2 | Completed | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB06215 | Ferumoxytol | Not Available | Completed | 1 |
DB01592 | Iron | Not Available | Completed | 1 |
DB05294 | Vandetanib | Not Available | Completed | 1 |